Dear AuntMinnie Member,
In late-breaking news on Friday, the U.S. Centers for Medicare and Medicaid Services (CMS) has finalized its decision to remove the national coverage determination for the use of beta-amyloid PET in dementia and neurodegenerative disease, thereby ending coverage with evidence development and paving the way for coverage of more than one PET scan per patient per lifetime.
As a result of the policy change, Medicare Administrative Contractors will now be able to determine Medicare coverage for beta-amyloid imaging. The CMS decision was applauded by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Medical Imaging and Technology Alliance (MITA). Get all of the details here.
Another CMS announcement also drew attention this week on AuntMinnie.com. Several organizations – including the American College of Radiology (ACR) and the Radiology Business Management Association (RBMA) -- have taken issues with new CMS guidance related to the No Surprises Act. Check out our article on the topic, as well as an accompanying video interview with Kathryn Keysor of the ACR, to learn more.
Here’s the full list of our top 5 stories of the week:
1. CMS finalizes new coverage policy for beta-amyloid PET in dementia and neurodegenerative disease.
2. New CMS guidance related to several provisions of the No Surprises Act drew criticism from several healthcare organizations, including the ACR and the RBMA.
3. AuntMinnie.com Associate Editor Amerigo Allegretto spoke with the ACR’s Kathryn Keysor to learn more about the potential impact of the new CMS guidelines.
4. Imaging consultant Michael J. Cannavo, AKA the PACSman, shares his predictions for the future of AI, PACS/enterprise imaging, and more in his new column: The PACSstradamus Prophecies.
5. A new study found that lung cancer incidence is on the rise among younger women.
